ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 169774 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 169774; 2) Community: the network communities that were significantly associated with the response to NSC 169774; 3) Molecule: the relationships between components within communities and NSC 169774; 4) MDR: the compounds that were significantly associated with the NSC 169774.

NSC Compound Enrichment Correlation
NSC 762559 Null 0.000572036815736145 -0.012377393
NSC 138425 Kinamycin C 0.000572036815736153 0.46645264
NSC 330500 Macbecin II 0.00057400073542549 0.22077967
NSC 354671 1-Piperazinecarbothioic acid, 4-(2-pyridinyl)-, [1-(2- thiazolyl)ethylidene]hydrazide 0.00057400073542549 0.62298667
NSC 618757 (E,E)-Piperidinium, 3,5-bis{[4-(dimethylamino)phenyl]methylene}-1,1-dimethyl-4-oxo, iodide 0.00057400073542549 0.31926449
NSC 641536 Quinoline-3-carboxylic acid, 6-chloro-4-phenyl- 2-[(piperazin-1-yl)methyl]-, ethyl ester 0.00057400073542549 0.18075949
NSC 683834 Null 0.00057400073542549 0.44776634
NSC 743864 Null 0.00057400073542549 0.35523375
NSC 113951 6-Bromotoyocamycin 0.000574000735425498 0.49973971
NSC 639521 Cyclopentanone, 2-[(dimethylamino)methyl]-5-[(2-methoxy- phenyl)methylene]-2-(phenylmethyl)-, hydrochloride 0.000613655894404029 0.5232137
Total:146  Current:11    [First] [Prev] [Next] [Last]